Overall, this study reports newly identified and previously uncharacterized high-risk ApoE variant, L122P, contributing to altered Aβ binding and structural destabilization, and offers insights for precision-medicine approaches targeting variant-specific mechanisms in Alzheimer’s disease. The gene discussed is APOE; the disease is Alzheimer disease.